Iperion (NZSE:IPR) Revenue: NZ$0.00 Mil (TTM As of Mar. 2026)


What is Iperion Revenue?

Iperion NZSE:IPR Revenue is NZ$0.00 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

Iperion's revenue for the six months ended in Mar. 2026 was NZ$0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.00 Mil. Iperion's Revenue per Share for the six months ended in Mar. 2026 was NZ$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Iperion  (NZSE:IPR) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Iperion Revenue Related Terms

Iperion Revenue Historical Data

* Premium members only.

The historical data trend for Iperion's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Iperion Revenue Chart

Iperion Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Iperion Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NZSE:IPR vs CCCX, CEPF, BCSS: Revenue Comparison

For the Shell Companies subindustry, Iperion's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Iperion Revenue vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Iperion's Revenue distribution charts can be found below:

* The bar in red indicates where Iperion's Revenue falls into.


Iperion Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of NZ$0.00 Mil mean?
Iperion (NZSE:IPR) has a Revenue of NZ$0.00 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Iperion and its competitors.
Is Iperion's Revenue too high?
Iperion's current Revenue is NZ$0.00 Mil.
How does Iperion's Revenue compare to CCCX and CEPF?
Iperion's Revenue of NZ$0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Diversified Financial Services company?
A good Revenue depends on the Diversified Financial Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Iperion and its competitors. Iperion's current Revenue is NZ$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iperion stock overvalued right now?
Iperion (NZSE:IPR) has a current Revenue of NZ$0.00 Mil. The current Revenue is NZ$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Iperion (NZSE:IPR), the current Revenue is NZ$0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Iperion Business Description

Address c/o Duncan Cotterill, 50 Customhouse Quay, Level 5 Tower Building, Wellington, NTL, NZL, 6011
Iperion Ltd is engaged in the process of commercializing a novel antimicrobial coating product, being marketed under the name Pathoglaze. The company is engaged in manufacturing, selling, distributing, importing, and exporting a self-cleaning, transparent, antimicrobial surface coating product.